Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...
At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of ...
BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...
In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...
Belle da Costa Greene was a pioneering Black American librarian who became J.P. Morgan’s librarian, shaping the Morgan ...
Kaguya Komatsu has been named the first female CEO of J.P. Morgan Asset Management -Japan, succeeding Shoichi Ohkoshi, who ...
Highlights:,Tevogen Bio,(NASDAQ:TVGN),shared insights on AI-driven drug development at the J.P. Morgan Healthcare Conference.
Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing ...
Is BioMarin stock a bargain or a falling knife? Learn about key issues affecting its investment prospects and potential for recovery.
In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...
RBC Wealth Management continues to recruit top advisory talent away from large Wall Street firms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results